Accepted for/Published in: Journal of Participatory Medicine
Date Submitted: Dec 20, 2021
Date Accepted: Jun 22, 2022
Moving to Personalized Medicine Requires Personalized Health Plans
ABSTRACT
Quality-adjusted life years (QALY) seek to express the value of changes in quality and length of life in a single metric. They have become a widely used measure of health benefits in cost-effectiveness evaluations. Wrapped up in the logic of the QALY is the premise that a payer will be willing to cover “cost-effective” therapies, and that the QALY gains from a given intervention will of the same value, irrespective of the preferences and non-health characteristics of the patients. However, different individuals have different preferences, and thus there is room for greater patient participation in determining what is cost effective for themselves, rather than society as a whole.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.